Deutsche Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-12,359
Closed -$530K 4902
2019
Q2
$530K Buy
12,359
+8,517
+222% +$328K ﹤0.01% 3245
2019
Q1
$147K Buy
+3,842
New +$147K ﹤0.01% 4164
2018
Q3
Sell
-2,951
Closed -$96K 5354
2018
Q2
$96K Buy
+2,951
New +$89K ﹤0.01% 4564
2017
Q2
Sell
-69
Closed -$1K 4937
2017
Q1
$1K Sell
69
-4,487
-98% -$109K ﹤0.01% 4810
2016
Q4
$98K Sell
4,556
-393
-8% -$8.57K ﹤0.01% 4092
2016
Q3
$117K Buy
4,949
+257
+5% +$6.13K ﹤0.01% 3891
2016
Q2
$108K Buy
4,692
+4,567
+3,654% +$98.8K ﹤0.01% 4070
2016
Q1
$2K Sell
125
-1,745
-93% -$30.7K ﹤0.01% 5038
2015
Q4
$34K Buy
1,870
+692
+59% +$12.4K ﹤0.01% 4571
2015
Q3
$18K Hold
1,178
﹤0.01% 4803
2015
Q2
$20K Buy
+1,178
New +$21.1K ﹤0.01% 4901
2015
Q1
Sell
-5,332
Closed -$70K 5158
2014
Q4
$70K Buy
5,332
+4,532
+567% +$57.9K ﹤0.01% 4934
2014
Q3
$9K Buy
+800
New +$10.1K ﹤0.01% 5408

Other funds holding BSX

Deutsche Bank's BSX Position: Q2 2026 in Review

Deutsche Bank reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $37.8M and leaving 5,957,053 shares worth $254M. The position accounts for 0.07% of the portfolio, ranked #236.

Deutsche Bank first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $811M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Deutsche Bank held 5,957,053 shares of Boston Scientific worth $254M as of Q2 2026.
  • Deutsche Bank sold 696,222 Boston Scientific shares in Q2 2026, an estimated $37.8M.
  • Boston Scientific made up 0.07% of Deutsche Bank's portfolio in Q2 2026, its #236 holding.
  • Deutsche Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Boston Scientific position peaked at $811M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.